ABSTRACT We constructed chimeras of the rat [32 and [34 neuronal nicotinic subunits to locate the regions that contribute to differences between the acetylcholine (ACh) dose-response relationships of the cx3132 and cx3134 receptors. Expressed in Xenopus oocytes, the r receptor displays an ECs0 for ACh ~ 20-fold less than the ECs0 of the ct3134 receptor. The apparent Hill slope (napp) of ~t3132 is near one whereas the ct3134 receptor displays an nap p near two. Substitutions within the first 120 residues convert the EC50 for ACh from one wild-type value to the other. Exchanging just [32:104-120 for the corresponding region of [34 shifts the ECs0 of ACh dose-response relationship in the expected direction but does not completely convert the ECs0 of the dose-response relationship from one wild-type value to the other. However, substitutions in the [32:104-120 region do account for the relative sensitivity of the ~t3132 receptor to cytisine, tetramethylammonium, and ACh. The expression of [34-like (strong) cooperativity requires an extensive region of [34 ([34:1-301). Relatively short [32 substitutions ([32:104-120) can reduce cooperativity to [32-like values. The results suggest that amino acids within the first 120 residues of [32 and the corresponding region of [34 contribute to an agonist binding site that bridges the et and [3 subunits in neuronal nicotinic receptors.
INTRODUCTION
Both the ot and non-~t subunits of the nicotinic acetylcholine receptor (nAChR) play a role in the activation of the receptor by agonist (reviewed in Deneris, Connolly, Rogers, and Duvoisin, 1991; Karlin, 1993; Papke, 1993) . Although many studies show that agonist binds to the tx subunit (reviewed in Karlin, 1993) , present opinion is divided about the possibility of an agonist binding site at the tx/non-et subunit interface (Cockcroft, Osguthorpe, Barnard, and Lunt, 1990; Karlin, 1993 ; Unwin, reveal a unique cleft within the a subunit that could act as an agonist binding pocket (Unwin, 1993) . However, there is no evidence that agonists actually bind within this cleft and contact only ec-subunit residues. On the other hand, previous experiments show that (a) the muscle-type a subunit (al) binds nicotinic agonists with appreciable affinities only if it is complexed with a non-c~ subunit (Blount and Merlie, 1988) and (b) the competitive antagonist d-tubocurarine (d-l'C) photolabels residues on the -y and G subunits of Torpedo nAChRs (Pedersen and Cohen, 1990; Chiara and Cohen, 1992) , which is strong evidence for a direct participation of the non-et subunits in an agonist binding site. However, dTC is a larger molecule than ACh and may not contact exactly the same residues that ACh does. Large quantities of purified neuronal nAChRs are not available for direct biochemical and structural analyses of potential agonist binding sites. We have exploited the fact that a3132 and et3134 neuronal nAChRs expressed in Xenopus oocytes display different relative sensitivities to the ganglionic agonists, cytisine (CYT), tetramethylammonium (TMA), acetylcholine (ACh) and nicotine (Leutje and Patrick, 1991; Figl, Cohen, Quick, Davidson, and Lester, 1992) , and different dose-response relationships for ACh (Couturier, Erkman, Valera, Rungger, Bertrand, Boulter, Ballivet, and Bertand, 1990; Cachelin andJaggi, 1991; Leutje, Piattoni, and Patrick, 1993; Wong, Mennerick, Clifford, Zorumski, and Isenberg, 1993) , to locate the residues of 132 and 134 involved in agonist activation of the receptor.
In an earlier study on coexpressed c~3 and 13 subunits, we used 134"132 chimeras. Extending the 134 NHe-terminal region of a chimera from residues 134:1-105 to 134:1-122 ( Fig. 1 ) changed the CYT/ACh and TMA/ACh response ratios from ~3132-1ike (132-like) to c~3134-1ike (134-like) levels (Figl et al., 1992) . These data suggested that 134:106-122, and the corresponding region of 132 (132:104-I20), contributes to an agonist binding site that bridges the a and non-a subunits. To test this hypothesis, we have extended the earlier studies with (a) more chimeric and mutated 13 subunits and (b) electrophysiological measurements of the agonist doseresponse relationship, which we summarize by the half-maximal agonist concentration (ECs0) and Hill coefficient (napp) . The results show that the region of 134 that converts the ECs0 for ACh from a 132-like to a 134-like value overlaps the previously localized region that converts the CYT/ACh response ratios of 134 NH2-terminal chimeras from 132-like to 134-like values (Figl et al., 1992) and suggest that an important component of the agonist binding site lies within the first 120 residues of 132 and the corresponding region of 134. Some of our results have been reported previously in abstract form (Figl, Cohen, Gollub, Davidson, and Lester, 1993) .
METHODS

Construction of the ~ Chimeras and Mutants
We created chimeras between the 132 and 134 subunits by taking advantage of shared restriction sites in the two subunits and using the polymerase chain reaction (PCR) to generate overlapping cDNA fragments (Higuchi, 1990 ) from the two subunits. Fig. 1 shows an alignment of 132 and 134 amino-acid sequences. Most of the chimeras contained the NH2-terminal region from one 13 subtype joined to the succeeding COOH-terminal residues from the other 13 subtype (NH~-terminal chimeras). We refer to the NHe-terminal chimeras in the text by transition points between the two types of 13 subunits. For example, 132(229)'134 is a chimera containing the first 229 residues of 132 joined to residues 232-475 of 134 (see Fig. 1 ). Chimeras containing internal substitutions are labeled by the end points of the substitution. For example, '134 is a chimera in which we substituted 132:104-120 for residues 106-122 of the 134 subunit (these labels have been shortened to 132(104-120) and 134(106-122) in Figs. 7 and 8) .
To create the 132(229)'134 and 134(231)'132 chimeras, we excised the cDNA fragments for residues 132:1-229 and 134:1-231 from the wild-type subunits with EcoRI and BbsI, subcloned the excised fragments into the complementary restricted plasmid from the opposite 13 subunit, and sequenced the region around the 134/132 transition to check the final product. The remaining chimeras were constructed in three steps: (a) we synthesized two or more separate PCR fragments; (b) we annealed and amplified the PCR fragments; and (c) we inserted the annealed fragment into the appropriate restriction sites in the wild-type plasmid. We normally introduced a silent mutation into the chimera during the initial PCR reaction to allow us to check the final product by restriction analysis. In addition, all the chimeras were verified by DNA sequencing. We made point mutations using the Altered Sites Kit (Promega Corp., Madison, WI) and verified the mutations by restriction analysis and DNA sequencing. Point mutations are denoted in the text by subscripts that contain the single letter code for the original residue, followed by its position in the sequence, and the residue to which it was mutated. We synthesized mRNA in vitro using the MEGAscript Kit (Ambion, Austin, TX) or a previously published method (Guastella, Nelson, Nelson, Czyzyk, Keynan, Midel, Davidson, Lester, and Kanner, 1990) and checked the size of the synthesized mRNA by agarose gel electrophoresis.
Oocyte Expression
Stage V-VI Xenopus oocytes were isolated as described previously (Quick and Lester, 1994) and injected with mRNA in a stoichiometric ratio for 0L:13 of 2:3. The amount of mRNA injected (< 25 ng/subunit) was adjusted to maintain a maximum response (/max) of < 10 ~ at -50 inV. Before recording, the oocytes were incubated for 2-7 d at 18~ in a modified Barth's solution supplemented with 50 ~g/ml gentamicin, 2.5 mM pyruvate, and 5% horse serum (Quick and Lester, 1994) .
Electrophysiological Recordings
The oocytes were voltage clamped at -50 mV with two, 3 M KCl-filled microelectrodes made from thick-walled borosilicate glass (model BF150-86-10, Sutter Instrument Co., Novato, CA) and an AxoClamp 2A voltage clamp (Axon Instruments, Foster City, CA). During the experiments, we perfused the recording chamber (~ 1.5 ml vol) with 98 mM NaCl, 1 mM MgC12, and 5 mM HEPES (pH 7.4) at room temperature (20-24~ at 10-20 mi/min. We omitted Ca ~+ from the recording solution because the entry of Ca 2 § through neuronal nAChRs can activate the endogenous Ca2+-activated C1-current of the oocyte (Vernino, Amador, Leutje, Patrick, and Dani, 1992) .
We applied agonists to the oocytes by pinching-off the outflow of a U tube (Bormann, 1992 ) with a solenoid-activated pinch valve (Cole-Palmer, Niles, IL) under computer control. The time constant of the approach to a steady state response ('to,) was 0.4-0.5 s at slowly desensitizing agonist doses. To check the effective [agonist] reaching the oocyte from the U tube, we applied a slowly desensitizing dose of ACh (1 IxM) to an oocyte expressing (x3132 using the bath and U tube perfusion systems. Bath and U tube application of 1 v.M ACh produced the same steady state response. Endogenous muscarinic responses were rare and easily identified by their oscillatory nature and delayed onset after agonist application from the U tube. We did not use oocytes exhibiting muscarinic responses.
Collection and Analysis of the Dose-Response Data
We recorded the responses to 6-11 different agonist doses to measure the dose-response relationships for individual oocytes. The agonist was applied in 6-s pulses separated by a 2-3-rain rinse with control saline. The responses were filtered at 20 Hz and digitized at a sampling frequency of 50 Hz using an MS-DOS computer equipped with pCLAMP V5.5 software (Axon Instruments).
We Iog [agonist] where/max was the maximum observed response and (b) from the log-log plot by regression at the foot of the dose-response relationship. The correlation between these two measurements of the napp was 0.89 for the 26 receptor types discussed in the text. Regression of the log-log slope against the corresponding Hill slope predicted a log-log slope of 1.1 for a Hill slope of 1.0 and a log-log slope of 1.9 for a Hill slope of 2.0. We preferred the estimates of the napp from the Hill plot because (a) the slope of the Hill plot was based on more points per oocyte than the initial log-log slope measurements, (b) log-log slope measurements tend to underestimate the true napp, (c) the Hill plot included more data points with a higher signal/noise ratio than the initial log-log plot, and (d) the n~pp'S from the Hill plot generally fit the dose-response relationship better than the napp'S from the log-log plots. The napp'S reported in the text are from Hill slopes rather than from log-log slopes unless stated otherwise. We weighted the residuals by 1/~/Ipeak for the fit to the Hill equation because the variance of Ipe~, at the high end of the dose-response relationship was larger than the variance of lp,a at the low end. Repeated measurements on a single oocyte showed that long-term desensitization reduced the/ma~ but did not affect the ECs0 or n~pp. To compare measurements of the ECs0 with widely different variances, we transformed the ECs0's to log values. Unless otherwise stated, the measurement errors reported in the text are standard deviations (SDs) and the SDs for the ECs0's given in the text are for untransformed data. To construct normalized dose-response relationships for the receptors, we normalized the individual dose-response relationships to the fitted lm.~'S and pooled the resulting data. We then refit the Hill equation allowing only the ECs0 to vary. The error reported for the normalized ECs0 measurements is the standard error of estimate (SEE).
Correction of the Peak Response for Desensitization
Rapid desensitization reduces the peak response because some receptors desensitize while the [agonist] is still rising around the oocyte. We used the following three-state scheme (Scheme I) to calculate depression of the peak response by rapid desensitization, kl k2
C---~O--->D,
SCHEMEI
where C, O, and D are the closed, open, and desensitized states of the receptor, k~ is the rate constant for the [ACh] to reach a steady state around the oocyte, and k 2 represents the rate constant for desensitization. We obtained kj directly from the rate constant of the rising phase of the response with 1 ~M ACh and k 2 directly from the rate constant of the decay of the response within the agonist pulse (in the Results section, 1/kl and 1/k2 are termed Ton and ~de~n). The relationship between the peak amplitude of the observed response (/peak) and the peak amplitude of the calculated response (Icalc) is,
At high [ACh]'s, the decay of the response consisted of two exponential components. These components were corrected separately using Eq. 1 and then summed to obtain the final calculated peak response.
RESULTS
The [3 Subunit Affects the Agonist Dose-Response Relationship
Consistent with previous data (Couturier et al., 1990; Leutje et al., 1993; Wong et al., 1993) , we found that the 13 subunit profoundly affects the sensitivity of neuronal nAChRs to ACh. Expressing a3 with [32, instead of with [34, shifted the ACh dose-response relationship at -50 mV considerably to the left and reduced its slope ( dose-response relationships for et3l~2 and a3134 to the Hill equation (Fig. 2 C) using the napp'S for a3132 and a3134 determined from Hill plots of the ACh responses (Fig.  2 D) . Similar to previous results (Couturier et al., 1990; Leutje et al., 1993; Wong et al., 1993) , the ECs0 for ACh was 11 -4 ~M (mean _+ SD, n = 29 oocytes) for the rat a3132 receptor and 219 -+ 12 txM (n = 3) for the rat et3134 receptor. The nap p for a3[~2 was 1. I _ 0.2 (n = 29) and the napp for a3134 was 2.2 -+ 0. I (n = 3). Fig. 2 D shows Hill plots for the two receptors. Measurements of the napp from the initial slope of a log-log plot of the dose-response relationship (where desensitization and agonist self-block are minimal) gave similar, but slightly smaller, napp'S for cx3132 (0.9 + 0.1, n = 11) and ~3134 (1.9 + 0.1, n = 3). Fig. 2 E shows examples of the initial portions of the log(dose)-log(response) relationships for the two wild-type receptors. The agreement of these measurements shows that the difference between the napp'S of cx3132 and ~3134 was not due to desensitization or open-channel block by the agonist. Injecting equal amounts of mRNA generally gave much larger maximal ACh responses for ~x3134 than for cx3132 ( ~ 10-fold) but we did not study these differences further.
The dose-response relationships of ~x3[32 and r for TMA displayed differences comparable to, but less pronounced than, those for ACh (Fig. 3). Fig. 3 , A and B, shows sample responses of cx3132 (Fig. 3A) and ~x3134 (Fig. 3B) to TMA. Rapid desensitization is less pronounced for both wild-type receptors with TMA as the agonist. The ECs0 of cx3[32 for TMA (76 --11 o~M, n = 7) was fivefold smaller than that of cx3134 (424 ---94 p,M, n = 6) and the napp of r for TMA (1.4 -+ 0.1, n = 7) determined from Hill plots of the dose-response data was significantly smaller than the napp of r (2.0 --0.2, n = 6). As with ACh, the [32 subunit shifts the TMA dose-response considerably to the left (Fig. 3 C) . Thus, the [3 subunit affects the activation of neuronal nAChRs by an agonist that contains only the quaternary ammonium portion of the ACh molecule; and the effects of the [3 subunit on the agonist dose-response relationship persist even with an agonist that desensitizes the receptor more slowly than ACh.
Rapid Desensitization Fails to Account for Differences in the ECso'S of o_3[32 and a3134
The response of cx3132 to ACh (Fig. 2 A) desensitized more quickly than the response of ~3~4 to ACh (Fig. 2 B) . The time constant %n for activation of the ~3132 response to 1 p~M ACh to reach a steady state was 0.4-0.5 s. The time constant "rdesen for the desensitization of the a3~2 response decreased from 5-7 s at 3 ~M ACh to 0.6-0.8 s at 300 ~M ACh. Desensitization of the ~3132 response to 300 p-M ACh was biphasic with an additional slow time constant of 5-6 s. The ~3~4 receptor displayed little desensitization during the 6-s agonist pulse. The ~desen for ~3~4 was 5-6 s at 1-2 mM ACh and was too slow to measure at 20-500 ~M ACh.
We corrected the peak ACh response of the wild-type receptors for apparent desensitization (see Methods) and fit the corrected data to the Hill equation to determine how much of the difference in the ECs0's could be due to a difference in the rate of desensitization. Correcting the peak response of ~3132 for apparent desensitization left napp unchanged but increased the ECs0 of ~x3[~2 for ACh twofold. Desensitization of ~3~4 did not significantly affect the ACh dose-response relationship. Thus, allowing for the potential effects of desensitization, the ECs0 of ~3134 for ACh was still 10-fold larger than the ECs0 of ~3132. The differences in desensitization accounted for such a small fraction of the differences between the EC50's of the wild-type receptors that we decided not to attempt to correct the amplitudes of the peak responses. We were unable to resolve desensitization occurring on a time scale faster than 1 s (Maconochie and Knight, 1992 ) using our drug application system (see Methods). Such desensitization would produce an apparent decrease in the ECs0 of the dose-response relationship in our experiments.
NH2-Terminal Substitutions of 105 or More [34 Residues Increase the ECso for ACh
Substitutions of 94 or fewer 134 residues had only small effects on the ECs0 for ACh (Fig. 4 A) ; the ECs0's of the et3134(16)'132, et3134 (81) Fig. 1 ). The addition of these two substitutions increased the ECs0 of the [34 NH2-terminal chimeras from [32-like to [34-like levels. Therefore, we made the site-directed mutations [32M101T.I:106v tO change just these residues in the [32 subunit. The ECs0 of the mutated receptor for ACh (19 +-4 I,M, n = 5) was within a factor of two of the value for cx3152 (11 -+ 4 ~M). Thus, the increase in the EC~0 of or3154 (109) (Chiara et al., 1992; O'Leary, Filatov, and White, 1994) also suggest that a tryptophan (,/:Trp55, ~:Trp57) in the first 60 residues of the non-or subunits contributes to the agonist binding sites of the Torpedo nAChR.
We also made the mutation a3134(61)SZ8N'[32 to determine if the loss of a potential glycosylation site at [52:Asn26 was responsible for the slight decrease in the EC50 of 0t3154(61).[52 below that of ct3152. The ECs0 (6 -+ 3 tzM, n = 4) and napp (0.8 • 0.1, n = 4) of Ct3154(61)SZSN'[52 for ACh were not significantly different from the ECs0 (5 -+ 1 IrM, n = 6) and the nap p (1.0 4-0.1, n = 6) of or3154 (61) We are not surprised by the differences between the regions of [54 that affect the ECs0 and those that affect the napp. Areas of contact between the subunits outside the agonist binding site may affect the cooperativity of a multisubunit receptor (Koshland, Nemfithy, and Filmer, 1966 -terminal chimeras also suggest that these subunits contact each other somewhere between the end of the first putative transmembrane domain M1 and the initial portion of the M3-M4 intracellular loop. However, our data do not allow us to exclude the alternative hypothesis that these residue substitutions produce a conformational change in the receptor that affects cooperativity indirectly.
Increasing the nat~ to [34-like Values Requires an Extensive Region of [34
Substituting fl2:1-120 for the Corresponding Region of [34 Reduces the ECso to a [32-like Value
We constructed a number of [52-[54 chimeras to determine the region of the [52 subunit required to reduce the ECs0 of the chimeras to [32-like values (Fig. 5 A) . Similar to results for the [54"[52 chimeras, substituting the first 120 residues of [52 for the corresponding region of [54 reduced the ECs0 for ACh to 16 4-8 IxM (n = 3) which resembles the ECs0 of ct3152 (11 4-4 izM). Fig. 5 B shows the effect of this substitution on the ACh dose-response relationship. Substituting the first 92 residues of [52 also reduced the ECs0 for ACh (Fig. 5 A) . Thus, residue substitutions in the first 92 amino acids of 62 do affect the sensitivity of the receptor to agonist but this effect is masked in the 64 NH2-terminal chimeras.
There is an anomalous member of the ~2"[M series; the ECs0 of ct362(229)'[M for ACh was close to that of ct364 (Fig. 5 A ) . This anomalous ECs0 does not seem to be (Fig. 6) .
Thus, the results for the 64 and 62 NH2-terminal chimeras show that 132/134 substitutions in the first 120 residues of 132 and the first 113 residues of {34 are sufficient to convert the ECs0 for ACh from one wild-type value to another.
Short [32 NH2-Terminal Substitutions Disrupt the Cooperativity of the Receptor
[$2 NH2-terminal sequences of 92 or more residues reduced the napp for ACh to a value near that of ~3[$2 for ACh (1.1 -0.2) (Fig. 5 C) . Moreover, a single measurement of the napp (1.1) for 0~3 [$2(59) Exchanging Fig. 1 ) had an effect on the ECs0 and napp for ACh that was independent of substitutions elsewhere in the [3 subunits.
Substituting [32:104-120 for [34:106-122 Also Affects Agonist Selectivity
Previous data (Figl et al., 1992) show that extending the [34 region of a 134 NH2-terminal chimera from 134:1-105 to [34:1-122 increases the 30 ixM CYT/30 IxM ACh (CYT/ACh) and 100 t~M TMA/30 tzM ACh (TMA/ACh) response ratios from [32-like to 134-like levels. We tested the effects of exchanging 132:104-120 and 134:106-122 to determine whether these regions accounted for the effects of the 134 NH2-terminal chimeras on agonist selectivity. Substituting [32-104-120 for [34:106-122 reduced the CYT/ACh and TMA/ACh response ratios to 132-like values (Fig. 8, A and B) , but the reciprocal substitution [34:106-122 for 62:104-120 produced only a small increase in the CYT/ACh or TMA/ACh response ratios toward 134-like values. Thus, similar to the effects of [32 substitutions on cooperativity, short internal substitutions reduce, but do not restore, the relative sensitivity of the a3134 receptor to ganglionic agonists such as CYT and TMA. The structural basis for this correspondence between the effects of internal substitutions on agonist selectivity and cooperativity is unclear. Nonetheless, the effects of exchanging 134:106--122 and 132:104-120 on several measurements associated with agonist activation of the receptor suggest that these areas are places where the a and 13 subunits contact to form an agonist binding site.
The Sole M2 Substitution Does Not Affect the ACh Dose-Response Relationship
Dose-response relationships for nAChRs are affected by mutations at several residues in the M2 transmembrane domain (reviewed in Karlin, 1993) . There is a single 132/134 substitution in the M2 region (132:Va1253~--~134:Phe255). We made the reciprocal point mutations 134vz55v and 132v253r to test whether this substitution could shift the agonist dose-response relationship. Neither mutation significantly affected the ECs0 or napp. The napp of Ot3134F255V was 2.0 --+ 0.1 (n = 3); the napp of ot31327253F was 1.2 + 0.1 (n = 3); the ECs0 of a3134E255v was 231 -18 IxM (n = 3); and, the ECs0 of a3132v253~ was 9 -1 IxM (n = 3).
DISCUSSION
The data reported in this paper describe the steady state dose-response relations of chimeric and mutated 139 and 134 subunits expressed with the a3 subunit in oocytes.
The data show that the first 120 residues of 132 and a comparable, but slightly shorter, region of 134 largely account for the different ECs0's of the wild-type dose-response relationships. In the sharpest region of transition, chimeras that differ at only two residues have more than a 10-fold difference in the ECs0. However, when we examined the corresponding mutant 132M101T, F106V it retained the ECs0 of the wild-type 132 subunit. This important result shows that the two critical residues are interacting with other upstream residues during activation of the receptor. Longer substitutions in this region (132:104-120--,134:106-122 ) do affect (a) the ACh doseresponse relationship and (b) the relative responses to several ganglionic agonists. The domains we have identified that affect the EC50 probably affect agonist binding and may contribute to an agonist binding site that bridges the ot and [3 subunits. Our experiments also bear on the regions responsible for the cooperativity of the receptor (napp). Regions of the 13 subunits responsible for differences in the napp overlap with, but are not identical to, those responsible for differences in the EC50. The 132:104-120 and 134:106-122 regions affect both measures. However, for the 134 NHz-terminal chimeras, the transition from 132-like to 134-like cooperativity occurs more gradually than the transition from a 132-like to a 134-like ECs0 and requires an extensive NH2-terminal region of the 134 subunit. The high level of cooperativity of e~3134 is disrupted by short 132 substitutions. If receptor cooperativity is determined by areas of contact between the subunits (Koshland et al., 1966) , then one of these contact regions appears to lie in 132:104-120 and 134:106-122.
The differences we observed between the ACh dose-response relationships of the ~x3132 and ~x3134 receptors are similar to those reported previously by Couturier et al. (1990) , Leutje et al. (1993) , and Wong et al. (1993) but differ substantially from those reported by Cachelin et al. (1991 ) . Cachelin et al. (1991) report a much smaller value for the EC50 of a3134 for ACh (30 ~M) and a much larger value for the ECs0 of ~3132 for ACh (354 IxM). They report similar, but less diverse, napp'S for the two receptor subtypes (napp = 1.4 for c~3132; napp = 1.8 for a3134). The reason for this discrepancy is unclear but most of the previous measurements, including data from a mammalian expression system (Wong et al., 1993) , are consistent with our data.
The a3132(229)'134 chimera is anomalous because it displays a large, 134-like ECs0 for ACh even though it includes regions of sequence that confer a 132-like ECs0 in another chimera tested. Nonetheless, the a3132(229)'134 chimera exhibits a 132-like CYT/ACh response ratio and a 132-like irreversible block by neuronal bungarotoxin . Based on its agonist selectivity and affinity for neuronal bungarotoxin, we suggest that the large EC50 of this chimera arises from a change in the conformational states of the receptor that enhances the relative stability of the closed singly liganded receptor state (Koshland et al., 1966) rather than from a change in the agonist binding site.
Channel Block by the Agonist Fails to Account for Differences in the Napp
Measurements of the Hill coefficient at the foot of the dose-response relationship show that the differences between the napp'S of the wild-type receptors are not due to channel block by the agonist because open-channel block is minimal in this region. However, open-channel block by the agonist could reduce the apparent ECs0 of the agonist dose-response relationship. To assess the importance of this effect, we (Maconochie and Knight, 1992) , or 70-to 140-fold greater than the value required to bring the ECs0 for (x3132 to 24 p~M. Moreover, with a Ki of l0 ~M, the maximum response would occur at ~ 50 p,M ACh. Higher agonist concentrations would reduce the amplitude of the response, contrary to our data for (x3132 (Fig. 2A) . Additionally, the sole substitution in M2, which is thought to contain the binding site for open-channel blockers, has no effect. These results strongly suggest that agonist self-block does not account for the differences in the ECs0'S that we observed.
Residues in a Homologous Region of y and 6 Determine Curare Binding
Three residue substitutions in the mouse ~/ and 5 subunits ('y:Ilell6(--~5:Valll8, ~/:Tyrll7(--)~:Thrll9, ~:Ser161(--)8:Lys163) account for a 10-fold increase in the affinity of the (x[3~/ receptor over the cx[35 receptor for the competitive antagonist (+)-dimethyltubocurarine (Sine, 1993) . Residues [32:Ilel 18 and [32: Phe119 in the rat neuronal nicotinic receptor are homologous to ~:Ile116 and ~:Tyrl 17 in the mouse receptor and they are in the [32:104-120 domain of the rat neuronal nicotinic receptor. More recent evidence (Xie, Chiara, and Cohen, 1994) shows that the competitive antagonist dTC also photolabels residues ~/:Tyrl 11 and ~/:Tyrl 17 in the Torpedo nAChR (homologous to [32:Ser113 and [32: Phel19 in the rat neuronal nicotinic receptor). Thus, in a domain homologous to 132:104-120 in the rat neuronal nicotinic receptor, we find (a) residues in the Torpedo ~ subunit that are photolabeled by dTC and (b) residues in the mouse "y and 5 subunits that affect competitive antagonist binding. Residues in [32:104-120 affect the napp, the EC~0, and agonist selectivity of neuronal nicotinic receptors. The proximity of residues in the muscle-type nicotinic receptors that affect binding and photolabeling by a competitive antagonist with those in the neuronal nicotinic receptor that affect the napp, the ECs0, and agonist selectivity supports the hypothesis that residues [32:104-120 contribute to an ~/[3 ligand binding site in neuronal nAChRs.
Differences in Channel Gating Do Not Account for Differences in the Wild-Type ECso
We consider a simple sequential model to suggest that differences in agonist binding, rather than in the rates of conformational change, are primarily responsible for the difference between the ECs0's of c~3~2 and 0t3134 for ACh. This kinetic scheme (Scheme II) can be summarized as follows, According to the data of Papke and Heinemann (1991) , Kz = 1.1 and 0.45, and K3 = 10 and 20 for 0t3~2 and a3~4, respectively. The point here is not the absolute values of these numbers, but the fact that they differ by relatively small amounts for the two receptors 9 A similar conclusion is reached from our own kinetic data on voltage-jump relaxations, to be published separately. These differences would change the ECs0 by less than twofold. Thus, differences in the cooperativity of binding and conformational transitions of 0t3132 and ct3134 cannot account for the 20-fold difference we observed between the ECs0's of the wild-type receptors for ACh. This model suggests that the wild-type dissociation constants for agonist binding (K(s) differ by more than 10-fold. Regardless of the particular kinetic model used, the differences between the mean open times of the 0t3132 and ct3~4 channels do not account for the differences in the ECs0'S ofct3~2 and 0t3~4 for ACh. The open channel lifetime is usually interpreted as the rate constant for leaving the open state of the channel 9 The long open-channel lifetime of the primary a3134 channel is 75% greater than the long open channel lifetime of the primary a3~2 channel (Papke et al., 1991) . All else being equal, this difference in open channel lifetime would be associated with a smaller ECs0 for 0t3~4 than for c,3~2, contrary to the data 9
Conclusions
Our study is the first attempt to determine the regions of sequence that account for the differences in the complete agonist dose-response relationship produced by two naturally occurring subunits of a channel. Past experiments on binding of antagonists or open-channel blockers have pinpointed just a few residues; however, channel activation in response to agonists is certainly a more complex phenomenon, involving binding, conformational changes, and interactions between the subunits. It is therefore encouraging that clear trends emerge from the data. Our results emphasize the involvement of one region, 62:104-120, in the binding event and suggest that a broader region of sequence is involved in the subunit contacts and/or conformational changes that open the channel.
